CGP-40215A

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCGP-40215A
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosylmethionine decarboxylase inhibitors
TargetsAdenosylmethionine decarboxylase
Therapy Area/IndicationsNeoplasmsMalariaPneumonia, Pneumocystis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsNeoplasmsMalariaPneumonia, Pneumocystis

Other Information

ATC CodeN/A
Related LinksN/A